Interneurons make up 25% of human cortical neurons, but their developmental origins remain mysterious. Two recent papers provide evidence suggesting that, in humans, as in mice, most cortical ...

Interneuron Pharmaceuticals Inc. raised $25 million through a private placement of 3.125 million shares of common stock to institutional investors It sold the shares for about $8 per share. As of Dec.

In order to investigate the effects of perinatal insults on GABAergic interneuron development, the Children's research team, led by Helene Lacaille, Ph.D., in Dr. Penn's laboratory, subjected the new ...

Upbeat phase III findings outweighed less encouraging late-stage trial news, as big pharma provided a mixed bag of cancer findings – with one data batch to form... Structure Therapeutics Inc.’s stock ...